Suppr超能文献

经¹²⁵I-酪氨酰纤维二糖衍生化的静脉注射胺化β(1→3)聚葡萄糖的命运

Fate of intravenously injected aminated beta(1----3) polyglucose derivatized with 125I-tyraminyl cellobiose.

作者信息

Smedsrød B, Seljelid R

机构信息

Institute of Medical Biology, University of Tromsø, Norway.

出版信息

Immunopharmacology. 1991 May-Jun;21(3):149-58. doi: 10.1016/0162-3109(91)90020-y.

Abstract

Aminated beta(1----3)glucan (polyglucose, AG), a potent soluble immunomodulator, was radio-iodinated and traced after intravenous administration to rats. Since the glucose polymer cannot be 125I-labelled directly by conventional methods, the polysaccharide had to be substituted with an adduct which binds the radiolabel. To this end, tyraminyl cellobiose (TC) was coupled to amino groups of AG by means of cyanuric chloride. This procedure resulted in a degree of substitution corresponding to 3.6% (or 1 molecule of tyraminyl cellobiose being incorporated per 28 molecules of glucose). AG substituted with TC (TC-AG) could be labelled with 125I by conventional procedures. After intravenous administration of 125I-TC-AG the serum concentration dropped about 50% from 1 min to about 15 min after injection, while a further drop from 50% to about 25% was observed during the next 15-60 min. The finding that 60 min after injection most of the radioactivity was recovered in the kidneys and urine, together with the results from gel chromatography showing that the low Mw fraction of the injected material disappeared first from the circulation, suggests that the initial rapid phase of elimination is due mainly to glomerular filtration. The molecules that are too large for kidney excretion are taken up mainly by the liver (about 10% of injected dose) at a slower speed. This notion was supported by the finding that a preparation of high Mw glucan obtained by gel chromatography survived for a long period in the circulation, and was eliminated mainly by accumulation in liver, whereas a preparation of low Mw glucan was rapidly eliminated by glomerular filtration. Several days after injection the liver contained nearly 90% of the recovered radioactivity, whereas the kidneys and other organs contained only insignificant amounts. This indicates that radioactivity associated with the kidneys after 60 min reflects glomerular filtration, whereas radioactivity in liver results from uptake leading to lysosomal accumulation. Isolation of liver cells after injection disclosed that the radioactivity per cell was the same in Kupffer cells (KC) and liver endothelial cells (LEC), whereas the uptake per parenchymal cell (PC) was about 30% of the uptake per KC and LEC. It could be calculated that in the intact liver, the population of PC was responsible for 50% of the uptake, whereas the populations of LEC and KC contained 35% and 15%, respectively, of the total liver radioactivity. These findings raise the question whether not only KC, but also LEC and PC may be mediators of the immune responses caused by beta(1----3) polyglucose.

摘要

胺化β(1→3)葡聚糖(多聚葡萄糖,AG)是一种有效的可溶性免疫调节剂,经放射性碘标记后静脉注射给大鼠并进行追踪。由于这种葡萄糖聚合物不能通过传统方法直接用¹²⁵I标记,因此必须用能结合放射性标记的加合物对多糖进行取代。为此,通过三聚氯氰将酪胺纤维二糖(TC)与AG的氨基偶联。该过程导致的取代度相当于3.6%(即每28个葡萄糖分子中掺入1个酪胺纤维二糖分子)。用TC取代的AG(TC - AG)可以通过传统方法用¹²⁵I标记。静脉注射¹²⁵I - TC - AG后,血清浓度在注射后1分钟至约15分钟内下降了约50%,而在接下来的15 - 60分钟内又从50%下降到约25%。注射后60分钟大部分放射性在肾脏和尿液中回收的发现,以及凝胶色谱结果表明注射物质的低分子量部分首先从循环中消失,这表明消除的初始快速阶段主要是由于肾小球滤过。对于肾脏排泄来说太大的分子主要以较慢的速度被肝脏摄取(约为注射剂量的10%)。这一观点得到以下发现的支持:通过凝胶色谱获得的高分子量葡聚糖制剂在循环中存活很长时间,并且主要通过在肝脏中积累而被消除,而低分子量葡聚糖制剂则通过肾小球滤过迅速消除。注射几天后,肝脏含有近90%回收的放射性,而肾脏和其他器官含有的量微不足道。这表明注射后60分钟与肾脏相关的放射性反映了肾小球滤过,而肝脏中的放射性是由于摄取导致溶酶体积累。注射后分离肝细胞发现,每个细胞的放射性在库普弗细胞(KC)和肝内皮细胞(LEC)中相同,而每个实质细胞(PC)的摄取量约为每个KC和LEC摄取量的30%。可以计算出,在完整的肝脏中,PC群体负责摄取总量的50%,而LEC和KC群体分别占肝脏总放射性的35%和15%。这些发现提出了一个问题,即是否不仅KC,而且LEC和PC也可能是β(1→3)多聚葡萄糖引起的免疫反应的介质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验